Achieve Life Sciences
ACHV
45 hedge funds and large institutions have $14.4M invested in Achieve Life Sciences in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 10 closing their positions.
46% more call options, than puts
Call options by funds: $57K | Put options by funds: $39K
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
6% less funds holding
Funds holding: 48 → 45 (-3)
21% less capital invested
Capital invested by funds: $18.2M → $14.4M (-$3.74M)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Top Buyers
Top Sellers
ACHV Hedge Fund Activity: Q3 2015 in Review
45 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2015, worth a combined $14.4M — down 21% from $18.2M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ACHV and 7 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 14 added.
The largest buyer was Wexford Capital, opening a new position worth an estimated $819K. The largest seller was BVF Inc, exiting entirely with an estimated $2.38M sold.
- 45 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2015, down from 48 in Q2 2015.
- Funds reported $14.4M of Achieve Life Sciences stock for Q3 2015, down 21% quarter-over-quarter.
- 7 funds opened new Achieve Life Sciences positions in Q3 2015 and 10 closed out, a net change of -3 holders.
- The largest Achieve Life Sciences buyer in Q3 2015 was Wexford Capital, an estimated $819K added.
- The largest Achieve Life Sciences seller in Q3 2015 was BVF Inc, an estimated $2.38M sold.
Based on aggregated 13F filings for Q3 2015.